2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

@article{Elliott20142014EG,
  title={2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).},
  author={Perry M Elliott and Aris Anastasakis and Michael Andrew Borger and Martin Borggrefe and Franco Cecchi and Philippe Charron and Albert Hagege and Antoine Lafont and G Gianna Giovamma Limongelli and Heiko Mahrholdt and William J. McKenna and Jens Erik Mogensen and Petros Nihoyannopoulos and Stefano Nistri and Petronella G Pieper and Burkert Pieske and Claudio Rapezzi and Frans Hendrik Rutten and Christoph Tillmanns and H. V. Watkins},
  journal={European heart journal},
  year={2014},
  volume={35 39},
  pages={
          2733-79
        }
}
2D : two-dimensional 99mTc-DPD : 99mTechnetium-3,3-diphosphono- 1,2-propanodi-carboxylic acid ACE : angiotensin-converting enzyme AF : atrial fibrillation AL : amyloid light chain AR : aortic regurgitation ARB : angiotensin receptor blocker ATTR : amyloidosis-transthyretin type AV : atrioventricular BiVAD : biventricular assist device BNP : brain natriuretic peptide BPM : Beats per minute CCS : Canadian Cardiovascular Society CFC : cardiofacialcutaneous CHA2DS2-VASc : Congestive Heart failure… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 600 CITATIONS, ESTIMATED 38% COVERAGE

Prognostic implications of left ventricular asymmetry in patients with asymptomatic aortic valve stenosis.

  • European heart journal cardiovascular Imaging
  • 2018
VIEW 4 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy.

  • International journal of cardiology
  • 2017
VIEW 14 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation.

  • Circulation. Arrhythmia and electrophysiology
  • 2017
VIEW 21 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.

  • Circulation. Heart failure
  • 2017
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Impact of exercise-induced mitral regurgitation on hypertrophic cardiomyopathy outcomes.

  • European heart journal cardiovascular Imaging
  • 2016
VIEW 5 EXCERPTS
CITES RESULTS, BACKGROUND & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2013
2019

CITATION STATISTICS

  • 95 Highly Influenced Citations

  • Averaged 117 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 493 REFERENCES

Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

  • European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology
  • 2008
VIEW 29 EXCERPTS
HIGHLY INFLUENTIAL

Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.

  • Circulation journal : official journal of the Japanese Circulation Society
  • 2013
VIEW 28 EXCERPTS
HIGHLY INFLUENTIAL

Genetic biomarkers in hypertrophic cardiomyopathy.

  • Biomarkers in medicine
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL